MC
CORT icon

Menta Capital’s Corcept Therapeutics CORT Stock Holding History

Menta Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-67,993
Closed -$1.31M – 662
2017
Q3 		$1.31M Sell
67,993
-47,818
-41% -$713K 0.19% 178
2017
Q2 		$1.37M Sell
115,811
-153,416
-57% -$1.67M 0.16% 218
2017
Q1 		$2.95M Sell
269,227
-187,162
-41% -$1.64M 0.29% 96
2016
Q4 		$3.31M Buy
456,389
+67,807
+17% +$531K 0.28% 81
2016
Q3 		$2.53M Buy
388,582
+78,553
+25% +$457K 0.24% 122
2016
Q2 		$1.69M Buy
310,029
+27,999
+10% +$146K 0.23% 87
2016
Q1 		$1.32M Sell
282,030
-29,729
-10% -$116K 0.18% 127
2015
Q4 		$1.55M Buy
311,759
+37,340
+14% +$168K 0.2% 142
2015
Q3 		$1.03M Buy
274,419
+108,269
+65% +$549K 0.16% 227
2015
Q2 		$999K Buy
166,150
+21,200
+15% +$130K 0.16% 257
2015
Q1 		$812K Buy
144,950
+15,258
+12% +$55.2K 0.1% 328
2014
Q4 		$389K Buy
129,692
+83,392
+180% +$254K 0.06% 488
2014
Q3 		$124K Sell
46,300
-30,100
-39% -$79.7K 0.02% 558
2014
Q2 		$214K Buy
76,400
+52,300
+217% +$154K 0.04% 454
2014
Q1 		$105K Buy
24,100
+5,700
+31% +$19.9K 0.03% 357
2013
Q4 		$59K Buy
+18,400
New +$37.2K 0.02% 356

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Menta Capital's CORT Position: Q4 2017 in Review

Menta Capital sold out of Corcept Therapeutics (CORT) in Q4 2017, closing a stake of 67,993 shares — an estimated $1.31M sold.

Menta Capital first reported a position in CORT in Q4 2013 and held it in 16 quarters. The position peaked at $3.31M in Q4 2016. 190 funds tracked by Wall St. Rank hold CORT as of Q4 2017.

  • Menta Capital reported no remaining Corcept Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Menta Capital sold 67,993 Corcept Therapeutics shares in Q4 2017, an estimated $1.31M.
  • Menta Capital first reported a position in Corcept Therapeutics in Q4 2013 and held it in 16 quarters.
  • Menta Capital's Corcept Therapeutics position peaked at $3.31M in Q4 2016.
  • 190 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2017.

Based on Menta Capital's 13F filing for Q4 2017, filed 14 Feb 2018.